EAHP European Statements Survey 2017, focusing on sections 2 (Selection, Procurement and Distribution), 5 (Patient Safety and Quality Assurance) and 6 (Education and Research) [0.03%]
2017年EAHP欧洲声明调查，重点关注第2部分（选择、采购和分配）、第5部分（患者安全和质量保证）和第6部分（教育和研究）
Petr Horák,Jonathan Underhill,Aida Batista et al.
Petr Horák et al.
Objectives: The 2017 EAHP European Statements Survey focussed on sections 2, 5 and 6 of the European Statements of Hospital Pharmacy. Statistical data on the level of implementation and on the main barriers to implementat...
Petr Horák
Petr Horák
Gillian F Cavell
Gillian F Cavell
Junior doctors' communication with hospital pharmacists about prescribing [0.03%]
英国住院医师与药剂师关于处方的沟通交往
Michael Wilcock,Joanna Lawrence,Julie Blundell
Michael Wilcock
Stephanie Kohl
Stephanie Kohl
Progression of systemic lupus erythematosus associated with propofol administration: a case report [0.03%]
异丙酚相关系统性红斑狼疮进展一例报告
Yang Yu,Huan Gui,Kai Xiong et al.
Yang Yu et al.
Propofol is a sedative-hypnotic agent used as a general anaesthetic with a good safety profile. However, the potential risk for patients with systemic lupuserythematosus (SLE) receiving propofol remains unclear. We report the case of a pati...
Why shared-care arrangements for prescribing in attention deficit hyperactivity disorder may not be accepted [0.03%]
为什么执行注意缺陷多动障碍开药的共享责任安排可能不被接受
I M Carrington,J McAloon
I M Carrington
Objectives: To investigate the reasons for the failure of uptake of shared-care arrangements for prescribing in attention deficit hyperactivity disorder. ...
What do laypeople consider 'medication' and are they aware of modulators of a drug's effects? [0.03%]
普通民众如何界定“药物”及其效果调节剂的认知状况如何？
Alexander F J Send,Janina A Bittmann,Gerhard Dyckhoff et al.
Alexander F J Send et al.
Objectives: Healthcare providers expect patients to be responsible partners during drug treatment, who know potential risks impeding drug effects and are able to accurately report prescribed and non-prescribed medication....